Who owns PRELUDE THERAPEUTICS INC?
- Ticker: PRLD
- CUSIP Number: 74065p101
Tip: Access positions for across all investors
Analyze quarterly positions in Prelude Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Prelude Therapeutics stock
Who bought or sold PRELUDE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 11M | $32M | 0% | Dec 2025 |
|
| Baker Bros. Advisors | 10M | $15M | 0% | Sep 2025 |
|
| Vanguard Group | 1.4M | $4.1M | 42% | Dec 2025 |
|
| Millennium Management | 1.1M | $1.7M | 362% | Sep 2025 |
|
| Kynam Capital Management | 789k | $2.3M | 100% | Dec 2025 |
|
| Acadian Asset Management | 536k | $1.6M | -1% | Dec 2025 |
|
| Marshall Wace | 274k | $794k | 100% | Dec 2025 |
|
| Geode Capital Management | 273k | $792k | 25% | Dec 2025 |
|
| Renaissance Technologies | 271k | $787k | -50% | Dec 2025 |
|
| BlackRock | 266k | $772k | 0% | Dec 2025 |
|
| Two Sigma Advisers | 223k | $321k | -1% | Sep 2025 |
|
| Susquehanna International | 168k | $488k | 100% | Dec 2025 |
|
| TD Asset Management | 161k | $466k | 0% | Dec 2025 |
|
| Two Sigma Investments | 152k | $219k | -2% | Sep 2025 |
|
| State Street Corporation | 127k | $369k | 30% | Dec 2025 |
|
| Sphera Funds Management | 123k | $356k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 118k | $341k | 48% | Dec 2025 |
|
| Jane Street | 111k | $322k | 219% | Dec 2025 |
|
| OMERS Administration Corporation | 73k | $212k | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 71k | $200k | 2% | Dec 2025 |
|
| Point72 Asset Management | 59k | $172k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 54k | $77k | -40% | Sep 2025 |
|
| XTX Topco | 50k | $146k | 222% | Dec 2025 |
|
| Northern Trust | 50k | $145k | 38% | Dec 2025 |
|
| Colony | 50k | $145k | 100% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 46k | $134k | 100% | Dec 2025 |
|
| HPM Partners | 33k | $96k | -4% | Dec 2025 |
|
| Qube Research & Technologies | 22k | $63k | 100% | Dec 2025 |
|
| Prudential Financial | 16k | $45k | -40% | Dec 2025 |
|
| Hsbc Holdings | 14k | $40k | -1% | Dec 2025 |
|
| AQR Capital Management | 11k | $15k | -76% | Sep 2025 |
|
| FMR | 9.1k | $13k | -19% | Sep 2025 |
|
| Barclays | 8.6k | $25k | -1% | Dec 2025 |
|
| Royal Bank of Canada | 7.7k | $14k | 173% | Sep 2025 |
|
| Jpmorgan Chase & Co | 3.9k | $5.6k | 100% | Sep 2025 |
|
| SBI Securities | 2.7k | $7.9k | 0% | Dec 2025 |
|
| Caldwell Sutter Capital | 2.0k | $5.8k | 100% | Dec 2025 |
|
| UBS Group | 1.9k | $5.4k | -55% | Dec 2025 |
|
| NISA Investment Advisors | 1.6k | $4.7k | 0% | Dec 2025 |
|
| Pnc Financial Services | 1.2k | $3.4k | 0% | Dec 2025 |
|
| CWM | 692.00 | $2.0k | -43% | Dec 2025 |
|
| Group One Trading | 500.00 | $1.5k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 95.00 | $276.003500 | 83% | Dec 2025 |
|
| Optiver Holding B.V. | 20.00 | $58.000000 | 0% | Dec 2025 |
|
| IFP Advisors | 1.00 | $3.000000 | -94% | Dec 2025 |
|
Who sold out of Prelude Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2025 | 100k | $144k |
| GSA Capital Partners | Sep 2025 | 75k | $108k |
| Citadel Advisors | Jun 2025 | 34k | $27k |
| Hrt Financial | Sep 2025 | 17k | $24k |
| Tower Research Capital | Sep 2025 | 6.9k | $10k |
| Simplex Trading | Sep 2025 | 153.00 | $0 |
| EverSource Wealth Advisors | Sep 2025 | 89.00 | $127.999800 |
| SRS Capital Advisors | Sep 2025 | 15.00 | $22.000500 |